Pharvaris (PHVS) Invested Capital (2019 - 2026)

Pharvaris (PHVS) has 8 years of Invested Capital data on file, last reported at $276.7 million in Q1 2026.

• For the quarter ending Q1 2026, Invested Capital changed N/A year-over-year to $276.7 million; the trailing twelve-month figure through Mar 2026 stood at $276.7 million (changed N/A YoY), and the FY2025 full-year result was $306.5 million, up 5.76% from the prior year.
• Invested Capital for Q1 2026 stood at $276.7 million, down from $315.8 million in the prior quarter.
• Across five years, Invested Capital topped out at $413.2 million in Q4 2023 and bottomed at $152.3 million in Q4 2022.
• The 5-year median for Invested Capital is $286.1 million (2024), against an average of $288.8 million.
• The widest annual swing landed in 2022, when Invested Capital plunged 35.05%; it then jumped 171.35% in 2023.
• A 5-year view of Invested Capital shows it stood at $152.3 million in 2022, then surged by 171.35% to $413.2 million in 2023, then tumbled by 30.76% to $286.1 million in 2024, then grew by 10.36% to $315.8 million in 2025, then dropped by 12.38% to $276.7 million in 2026.
• The last three Invested Capital figures came in at $276.7 million (Q1 2026), $315.8 million (Q4 2025), and $286.1 million (Q4 2024), per Business Quant data.

Peer Comparison